Assessing transporter‐mediated rifampin–linezolid interaction using physiologically‐based pharmacokinetic modelling

Documenti analoghi

• Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
  di: Clifford G. Banda, et al.
  Pubblicazione: (2024)
• Population pharmacokinetics of lumefantrine in pregnant and non‐pregnant women with uncomplicated Plasmodium falciparum malaria in Western Kenya
  di: Elizabeth Juma, et al.
  Pubblicazione: (2025)
• Safety, tolerability and pharmacokinetics of DNDI‐6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants
  di: Jean‐Yves Gillon, et al.
  Pubblicazione: (2025)
• A drug–drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5‐lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam
  di: Jane Knöchel, et al.
  Pubblicazione: (2024)
• Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series
  di: Jeroen P. A. Houwen, et al.
  Pubblicazione: (2025)